The LATAM Media Report
SEE OTHER BRANDS

Your media and advertising news from Latin America

The LATAM Media Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.

Press releases published on April 28, 2025

U.S., Russia Report Progress Toward Ukraine Peace Efforts

U.S., Russia Report Progress Toward Ukraine Peace Efforts

(MENAFN) Russia and the United States have reported steps forward in efforts to resolve the conflict in Ukraine, pointing to the development of favorable conditions for launching talks aimed at achieving a durable peace. The Russian Foreign Ministry shared …

Albanese Secures Victory in Final Election Debate

Albanese Secures Victory in Final Election Debate

(MENAFN) Australian Prime Minister Anthony Albanese has emerged victorious in the fourth and final debate against opposition leader Peter Dutton ahead of the upcoming general election on Saturday. In a debate held on Sunday night, 50 percent of undecided …

Gaza Death Toll Surges: Over 65 Percent of Victims Are Women, Children, Elderly

Gaza Death Toll Surges: Over 65 Percent of Victims Are Women, Children, Elderly

(MENAFN) More than 65% of those killed in Israel’s ongoing military offensive on Gaza are women, children, and the elderly, local authorities reported on Sunday. The Gaza-based Government Media Office stated that since October 7, 2023, Israeli forces have …

Moderna Faces Possible Suspension from UK Pharmaceutical Trade Body

Moderna Faces Possible Suspension from UK Pharmaceutical Trade Body

(MENAFN) US pharmaceutical giant Moderna may be removed or suspended from a British industry group after reportedly breaking ethical guidelines, including giving children money and toys like teddy bears to participate in Covid vaccine research, based on …

Zelensky Says Ukraine Can’t Retake Crimea by Force

Zelensky Says Ukraine Can’t Retake Crimea by Force

(MENAFN) Ukrainian Leader Vladimir Zelensky has acknowledged that his country does not have the military capability needed to recapture Crimea by force. The peninsula became part of Russia in 2014 following a controversial referendum. This vote came after …

NANO Nuclear Announces Full Dismissal of Nevada Lawsuit

NANO Nuclear Announces Full Dismissal of Nevada Lawsuit

New York, N.Y., April 28, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that on …

Chengdu Will Mark 100-day Countdown to TWG 2025 Chengdu

Chengdu Will Mark 100-day Countdown to TWG 2025 Chengdu

CHENGDU, China, April 28, 2025 (GLOBE NEWSWIRE) -- On April 29, on the eve of International Workers' Day, the countdown to the TWG 2025 Chengdu will reach the critical 100-day mark. Chengdu, the host city, is welcoming the upcoming The World Games 2025 …

Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025

Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025

PETAH TIKVA, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced management’s participation in the 20th Annual …

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting

Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity Progression free survival (PFS) data to date represents a near doubling of the benchmarking …

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease

Initial real-world data from nearly 40,000 EYLEA HD patients will provide early insights on effectiveness of EYLEA HD in everyday clinical practice New indirect comparisons will evaluate EYLEA HD and faricimab on measures of efficacy, dosing frequency and …

Kandi Technologies Reports 2024 Financial Results

Kandi Technologies Reports 2024 Financial Results

Revenue Of $127.6M up 3.2% YoY, Supported by Expanded Product Reach And Improved Geographic Balance Electric Off-Road Vehicle Revenue Rose 8.9% YoY, Reinforcing Core Segment Leadership Enhanced Supply Chain Flexibility with Taiwan Upgrades, While …

Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting

Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting

LONDON and PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced …

Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025

Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its first quarter 2025 financial …

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including two clinical-stage programs, today …

CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Year-End 2024, Q1-2025, No Effects from Tariffs

CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Year-End 2024, Q1-2025, No Effects from Tariffs

Katy, Texas, April 28, 2025 (GLOBE NEWSWIRE) -- CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors audited financial results for Year …

Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

NEW HAVEN, Conn., April 28, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will review first …

Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients

Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients

EXTON, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- This spring, Lungpacer Medical clinical experts and device innovators will be featured presenters at top industry events. Speakers will demonstrate how novel interventional therapies can free critically ill …

Clear Blue Technologies International to provide Corporate Update and Report Fiscal 2024 Financial Results and Host Conference Call on Thursday, May 1st, 2025

Clear Blue Technologies International to provide Corporate Update and Report Fiscal 2024 Financial Results and Host Conference Call on Thursday, May 1st, 2025

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Clear Blue Technologies International Inc. (TSXV: CBLU) the Smart Off-Grid™ Company, today announces that it will provide a corporate update and also report financial results for its fiscal 2024 on Wednesday, …

Village Farms International Takes Top Honors at the 2025 Stevie® Awards

Village Farms International Takes Top Honors at the 2025 Stevie® Awards

VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) was named the winner of two Gold Stevie® Awards and one Bronze Stevie® Award in the 23rd Annual American …

Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting

Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting

NEWTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service